20 completed. 20 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 20 | Completed 20 |
Follow Kidney Failure: new trials by email Literature Review of Kidney Failure trials Research Report on Kidney Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia Empagliflozin 25 MG, Placebo - Hyponatremia, SIADH | Phase 4 | Completed | University Hospital, Basel, Switzerland | 113 | 2021-02-04 | 2026-09-22 |
| A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients Dalteparin - Kidney Failure | Phase 4 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 15 | 2016-08-01 | 2020-02-24 |
| IV Antibiotics With Lavage for Severe PD Peritonitis Intravenous vancomycin & gentamicin with adjunctive lavage, Intraperitoneal vancomycin & gentamicin - Peritonitis, Kidney Failure | Phase 4 | Completed | Alice Ho Miu Ling Nethersole Hospital | 46 | 2014-03-01 | 2018-01-31 |
| Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis Mycophenolate mofetil - Kidney Transplantation, Kidney Failure | Phase 4 | Completed | Clinical Hospital Merkur | 76 | 2013-05-01 | 2021-10-26 |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients Cinacalcet, Surgical total parathyroidectomy with forearm autografting - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Completed | The University of Hong Kong | 67 | 2010-05-10 | 2021-10-12 |
| 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy DDAVP, saline solution - Kidney Failure | Phase 4 | Completed | University of Bari | 162 | 2008-08-01 | 2015-01-13 |
| Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients cyclosporine or tacrolimus, sirolimus - Graft Rejection, Kidney Failure | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 121 | 2006-09-01 | 2011-05-30 |
| Study Evaluating Sirolimus in the Treatment of Kidney Transplant Sirolimus - Kidney Failure, Kidney Diseases | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 100 | 2006-08-01 | 2007-03-22 |
| Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Paricalcitol - Kidney Failure | Phase 4 | Completed | Fresenius Medical Care North America | 64 | 2006-03-01 | 2010-04-08 |
| CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation Campath, Daclizumab - Kidney Transplantation, Kidney Diseases | Phase 4 | Completed | EMagnusson | 123 | 2005-10-01 | 2021-09-29 |
| A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients Tacrolimus, Sirolimus, prednisone - Kidney Failure, Graft vs Host Disease | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 47 | 2005-08-01 | 2023-12-11 |
| PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography Simvastatin - Kidney Failure | Phase 4 | Completed | Seoul National University Hospital | 320 | 2005-02-01 | 2007-07-12 |
| NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization N-acetylcystein, ascorbic acid - Kidney Failure | Phase 4 | Completed | Seoul National University Hospital | 250 | 2005-02-01 | 2006-11-27 |
| Study Evaluating Sirolimus in Kidney Transplant Recipients in India Rapamune - Kidney Failure, Graft vs Host Disease | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 100 | 2004-04-01 | 2007-12-28 |
| Correction of Anaemia and Progression of Renal Failure on Transplanted Patients Neorecormon - Anaemia, Renal Transplantation | Phase 4 | Completed | Centre Hospitalier Universitaire, Amiens | 128 | 2004-04-01 | 2025-09-23 |
| Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus CYCLOSPORINE - Kidney Failure, Graft vs Host Disease | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 280 | 2004-03-01 | 2011-03-08 |
| Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients Sirolimus - Graft Rejection, Kidney Failure | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 420 | 2004-03-01 | 2007-12-27 |
| RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography Iodixanol(Drug) - Kidney Failure | Phase 4 | Completed | Seoul National University Hospital | 2004-01-01 | 2006-11-30 | |
| Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients Sirolimus - Kidney Failure, Graft Rejection | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 66 | 2002-10-01 | 2012-01-31 |
| Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients tacrolimus, mycophenolate mofetil, methylprednisolone - Graft Rejection, Kidney Failure | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 160 | 2006-05-19 |
Renal Insufficiency (20) · Graft vs Host Disease (3) · Kidney Diseases (2) · Anemia (1) · Bronchiolitis Obliterans Syndrome (1) · Diabetes Insipidus (1) · Hemorrhage (1) · Hyperparathyroidism, Secondary (1) · Hyponatremia (1) · Inappropriate ADH Syndrome (1) · Inflammation (1) · Kidney Failure, Chronic (1) · Liver Failure (1) · Peritonitis (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (20) · Female Urogenital Diseases and Pregnancy Complications (20) · Male Urogenital Diseases (20) · Urogenital Diseases (20) · Urologic Diseases (20) · Kidney Diseases (18) · Immune System Diseases (4) · Endocrine System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2) · Digestive System Diseases (2) · Disease Attributes (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Sirolimus (7) · Tacrolimus (3) · Cyclosporine (2) · Mycophenolic Acid (2) · Alemtuzumab (1) · Ascorbic Acid (1) · Cinacalcet (1) · Cyclosporins (1) · Daclizumab (1) · Dalteparin (1) · Deamino Arginine Vasopressin (1) · Erythropoietin (1) · Gentamicins (1) · Methylprednisolone (1) · Prednisolone (1)
Wyeth is now a wholly owned subsidiary of Pfizer (8) · Seoul National University Hospital (3) · Alice Ho Miu Ling Nethersole Hospital (1) · Centre Hospitalier Universitaire, Amiens (1) · Clinical Hospital Merkur (1) · EMagnusson (1) · Fresenius Medical Care North America (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · The University of Hong Kong (1) · University Hospital, Basel, Switzerland (1) · University of Bari (1)
South Korea (3) · Brazil (2) · Canada (2) · Hong Kong (2) · Spain (2) · Switzerland (2) · United States (2) · Australia (1) · Austria (1) · Croatia (1) · France (1) · Germany (1) · India (1) · Italy (1) · Mexico (1)
Byung-Hee Oh, M.D., Ph.D. (3) · Sang-Ho Jo, M.D. (3) · Hyo-Soo Kim, M.D.,Ph.D. (2) · Adam G McLean, FRCP, DPhil (1) · Angela YM Wang, MD, PhD (1) · Bon-Kwon Koo, M.D., Ph.D. (1) · Bon-Kwon Koo, M.D.,Ph.D. (1) · Carlo Manno, MD (1) · David H Taube, MBBCh, FRCP (1) · Franck Martinez, MD, PhD (1) · Gabriel Choukroun, MD, PhD (1) · Hyo-Soo Kim, M.D., Ph.D. (1) · Julie Refardt, MD (1)
PMID 16949481, PMID 18294484, PMID 21354681, PMID 21836540, PMID 22193388, PMID 22776430, PMID 36791280, PMID 36869794, PMID 38040277, PMID 39382091
2005 (1)